Methylation of the miR-126 gene associated with glioma progression

详细信息    查看全文

• 作者：Hongwei Cui ; Yongping Mu ; Lei Yu ; Ya-guang Xi ; Rune Matthiesen…
• 关键词：miR ; 126 ; Glioma ; Down ; regulation ; Methylation
• 刊名：Familial Cancer
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：15
• 期：2
• 页码：317-324
• 全文大小：1,230 KB
• 参考文献：1.Di Stefano AL, Enciso-Mora V, Marie Y, Desestret V, Labussiere M, Boisselier B et al (2013) Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Neuro Oncol 15:542–547CrossRef PubMed PubMedCentral
  2.He LW, Shi R, Jiang L, Zeng Y, Ma WL, Zhou JY (2014) XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis. PLoS One 9:e111981CrossRef PubMed PubMedCentral
  3.Huse JT, Holland EC (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10:319–331CrossRef PubMed
  4.Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507CrossRef PubMed
  5.Yu J, Cai X, He J, Zhao W, Wang Q, Liu B (2012) Microarray-based analysis of gene regulation by transcription factors and microRNAs in glioma. Neurol Sci 34:1283–1289CrossRef PubMed
  6.Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351–1358CrossRef PubMed
  7.Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS et al (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28:5369–5380CrossRef PubMed PubMedCentral
  8.Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M et al (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14CrossRef PubMed PubMedCentral
  9.Hansen TF, Nielsen BS, Jakobsen A, Sorensen FB (2015) Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study. J Transl Med 13:10CrossRef PubMed PubMedCentral
  10.Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838CrossRef PubMed
  11.Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147–152CrossRef PubMed PubMedCentral
  12.Zhang J, Du YY, Lin YF, Chen YT, Yang L, Wang HJ et al (2008) The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 377:136–140CrossRef PubMed
  13.Ebrahimi F, Gopalan V, Smith RA, Lam AK (2013) miR-126 in human cancers: clinical roles and current perspectives. Exp Mol Pathol 96:98–107CrossRef PubMed
  14.Baskerville S, Bartel DP (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241–247CrossRef PubMed PubMedCentral
  15.Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14:1902–1910CrossRef PubMed PubMedCentral
  16.Kim YK, Kim VN (2007) Processing of intronic microRNAs. EMBO J 26:775–783CrossRef PubMed PubMedCentral
  17.Smith ZD, Meissner A (2013) DNA methylation: roles in mammalian development. Nat Rev Genet 14:204–220CrossRef PubMed
  18.Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T, Konishi N (2005) Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 41:161–169CrossRef PubMed
  19.Nakahara Y, Shintani S, Mihara M, Hino S, Hamakawa H (2006) Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg 35:362–365CrossRef PubMed
  20.Moreira PR, Guimaraes MM, Guimaraes AL, Diniz MG, Gomes CC, Brito JA et al (2009) Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. J Oral Pathol Med 38:99–103CrossRef PubMed
  21.Mirimanoff RO (2014) High-grade gliomas: reality and hopes. Chin J Cancer 33:1–3CrossRef PubMed PubMedCentral
  22.Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355CrossRef PubMed
  23.Lee YS, Dutta A (2009) MicroRNAs in cancer. Annu Rev Pathol 4:199–227CrossRef PubMed PubMedCentral
  24.Ghildiyal M, Zamore PD (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10:94–108CrossRef PubMed PubMedCentral
  25.Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114CrossRef PubMed
  26.Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379CrossRef PubMed
  27.Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205CrossRef PubMed
  28.Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233CrossRef PubMed PubMedCentral
  29.Han L, Yue X, Zhou X, Lan FM, You G, Zhang W et al (2012) MicroRNA-21 expression is regulated by beta-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther 18:573–583CrossRef PubMed
  30.Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–6033CrossRef PubMed
  31.Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH et al (2009) MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem 23:347–358CrossRef PubMed
  32.Xia H, Qi Y, Ng SS, Chen X, Chen S, Fang M et al (2009) MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun 380:205–210CrossRef PubMed
  33.Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S et al (2009) microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res 1269:158–165CrossRef PubMed
  34.Jiang L, Mao P, Song L, Wu J, Huang J, Lin C et al (2010) miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177:29–38CrossRef PubMed PubMedCentral
  35.Yu F, Zheng J, Mao Y, Dong P, Li G, Lu Z et al (2015) Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis. Biochem Biophys Res Commun 463:679–685CrossRef PubMed
  36.Xiong Y, Kotian S, Zeiger MA, Zhang L, Kebebew E (2015) miR-126-3p inhibits thyroid cancer cell growth and metastasis, and is associated with aggressive thyroid cancer. PLoS One 10:e0130496CrossRef PubMed PubMedCentral
  37.Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N et al (2014) Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget 5:11873–11885CrossRef PubMed PubMedCentral
  38.Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379:726–731CrossRef PubMed
  
• 作者单位：Hongwei Cui (1)
  Yongping Mu (2)
  Lei Yu (3)
  Ya-guang Xi (1)
  Rune Matthiesen (4)
  Xiulan Su (1)
  Wenjie Sun (5) (6)
  
  1. Clinical Medical Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China
  2. Clinical Laboratory of Inner Mongolia Autonomous Region Tumor Hospital, Hohhot, Inner Mongolia, China
  3. Pharmacy Department of Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot, Inner Mongolia, China
  4. Department of Genetics, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal
  5. School of Food Science, Guangdong Pharmaceutical University, Zhongshan, 528458, China
  6. School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Human Genetics
  Epidemiology
  
• 出版者：Springer Netherlands
• ISSN：1573-7292

文摘

Gliomas are the most common and the most malignant brain tumors, accouting for 45–55 % of all intracranial tumors. The incidence of glioma worldwide is about 6–12 per 100,000. Recently, several studies showed that the activation of the oncogenes and the inactivation and/or loss of the tumor suppressor genes, especially for miRNA-21, let-7 and so on, are the most primary molecule event in gliomas. MicroRNAs (miRNAs) are a class of endogenously expressed small noncoding RNAs which are usually 21–23 nucleotides long. miRNAs regulate gene expression and play important roles in a variety of physiological and pathological processes, such as cell proliferation, differentiation and apoptosis. To date, Growing evidence has shown that mi RNAs are frequently dysregulated in human cancers and can act as both tumor suppressors and oncogenes. Along with the discovery of micro RNA, more and more research focusing on its relationship with glioma was carried out to investigate the biological features of glioma and to provide experimental evidence for glioma mechanism. In the present study, we aimed to verify the miRNA-126 down-regulation which showed in the results of glioma tissue miRNAs chip and discuss the miRNA-126 methylation in patients with glioma. A total of 50 samples from patients with glioma and 20 control samples from patients with cerebral trauma were included in this study. The expression levels of the miR-126 gene were detected using quantitative polymerase chain reaction (PCR), and the methylation status of miR-126 was examined using methylation-specific PCR-denaturing high-performance liquid chromatography (MSP–DHPLC). The expression level of miRNA-126 was found to be significantly higher in the control group (0.6134 ± 0.1214) than in the glioma group (0.2771 ± 0.1529; P < 0.05). The expression was also significantly elevated in low-grade gliomas (0.3117 ± 0.1474) compared with high-grade gliomas (0.1582 ± 0.1345; P < 0.05). In addition, increased methylation of miR-126 was found in 40 % of glioma patients in our study (20/50 cases), resulting in significantly decreased miR-126 expression (0.1715 ± 0.1376; P < 0.05). Our results indicate that we verified successfully the miRNA-126 down-regulation phenomenon in patients with glioma which showed in the results of glioma tissue miRNAs chip and the miRNA-126 down-regulation through methylation in patients with glioma. So we could say that epigenetic modification is a crucial mechanism for controlling the expression of miR-126 in glioma.